Q32 Bio Inc (QTTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 48,297 | 77,965 | 25,617 | 33,986 | 108,382 |
| Marketable Securities | N/A | N/A | N/A | 141,040 | 47,491 |
| Other current assets | 0 | 0 | 0 | 0 | 28,907 |
| TOTAL | $55,050 | $81,877 | $28,716 | $181,015 | $191,909 |
| Non-Current Assets | |||||
| PPE Net | 979 | 1,370 | 1,782 | 1,078 | 2,252 |
| Investments And Advances | 0 | 2,600 | 0 | 25,814 | 0 |
| Other Non-Current Assets | 5,747 | 6,485 | 16,559 | 20,563 | 17,560 |
| TOTAL | $6,726 | $10,455 | $18,341 | $47,455 | $19,812 |
| Total Assets | $61,776 | $92,332 | $47,057 | $228,470 | $211,721 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,235 | 3,097 | 878 | N/A | N/A |
| Accounts payable and accrued liabilities | 879 | 2,989 | 3,468 | 1,144 | 2,366 |
| Accrued Expenses | 4,232 | 7,479 | 9,763 | 18,715 | 11,406 |
| Other current liabilities | N/A | 2,900 | N/A | N/A | N/A |
| TOTAL | $11,346 | $16,465 | $14,109 | $22,576 | $17,226 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,473 | 9,556 | 4,581 | N/A | N/A |
| Deferred Revenues | N/A | N/A | N/A | 1,156 | 3,208 |
| Other Non-Current Liabilities | 4,943 | 60,636 | 99,843 | 27,916 | 23,688 |
| TOTAL | $8,416 | $70,192 | $104,424 | $27,916 | $24,844 |
| Total Liabilities | $19,762 | $86,657 | $118,533 | $50,492 | $42,070 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,629 | 12,198 | 663 | 3,207 | 3,191 |
| Common Shares | 2 | 2 | 1 | 6 | 6 |
| Retained earnings | -204,993 | -234,814 | -187,081 | -429,137 | -424,132 |
| Other shareholders' equity | 0 | 0 | 111,445 | -404 | -7 |
| TOTAL | $42,014 | $5,675 | $-71,476 | $177,978 | $169,651 |
| Total Liabilities And Equity | $61,776 | $92,332 | $47,057 | $228,470 | $211,721 |